
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.370 | 1.650 | 0.280 |
Shares | 98.620 | 98.620 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.221 | 17.162 |
Price to Book | 1.587 | 2.218 |
Price to Sales | 1.647 | 1.808 |
Price to Cash Flow | 8.494 | 11.783 |
Dividend Yield | 4.698 | 2.934 |
5 Years Earnings Growth | 4.866 | 6.818 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 42.510 | 21.118 |
Industrials | 39.480 | 40.347 |
Healthcare | 8.670 | 10.285 |
Technology | 3.850 | 8.116 |
Consumer Defensive | 3.610 | 4.541 |
Basic Materials | 1.880 | 4.630 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Investor B | SE0015811963 | 9.57 | 308.8 | -1.11% | |
Volvo B | SE0000115446 | 8.95 | 255.70 | -0.08% | |
Swedbank A | SE0000242455 | 8.57 | 285.70 | -0.35% | |
Nordea Bank | FI4000297767 | 6.87 | 14.645 | +0.45% | |
Traton | DE000TRAT0N7 | 5.29 | 26.02 | -0.99% | |
Danske Bank | DK0010274414 | 4.85 | 273.3 | +0.26% | |
Sandvik AB | SE0000667891 | 4.59 | 280.80 | +0.47% | |
SKF B | SE0000108227 | 4.53 | 238.7 | +0.13% | |
SEB A | SE0000148884 | 4.41 | 180.95 | -0.06% | |
AstraZeneca | GB0009895292 | 4.29 | 12,468.0 | -0.76% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Sverige Indexfond | 50.79B | 4.50 | 14.41 | 10.08 | ||
SEB Sverige Indexfond utd | 50.79B | 3.91 | 11.16 | 9.52 | ||
SEB Sverige Indexfond Institutional | 50.79B | 0.72 | 6.90 | 8.43 | ||
SEB Varldenfond | 38.87B | -2.55 | 9.76 | 5.88 | ||
SEB Sverigefond Smabolag C R | 24.18B | 2.15 | 13.22 | 16.15 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review